<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03952208</url>
  </required_header>
  <id_info>
    <org_study_id>18-006578</org_study_id>
    <nct_id>NCT03952208</nct_id>
  </id_info>
  <brief_title>Neurocognitive Dysfunction After Anesthesia in Patients With Recent Concussion</brief_title>
  <official_title>Neurocognitive Dysfunction After Anesthesia in Patients With Recent Concussion</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mayo Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mayo Clinic</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Researchers are trying to determine if the impact of a concussion on the brain is affected by
      anesthesia and surgery.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      All subjects will complete pre and post procedure assessments prior to undergoing a planned
      surgery/anesthetic standard of care.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 21, 2019</start_date>
  <completion_date type="Anticipated">December 2022</completion_date>
  <primary_completion_date type="Anticipated">December 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Wide Range Achievement Test Fourth Edition, WRAT-4</measure>
    <time_frame>Pre-anesthetic to one week Post-anesthetic</time_frame>
    <description>Change in WRAT-4</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Numeric Pain Scale 0-10</measure>
    <time_frame>Post-operatively to hospital discharge, up to 10 days.</time_frame>
    <description>Difference in numeric pain scale between the concussion and non-concussion group. Patients verbally select a value that is in line with the intensity of pain they have experienced in the last 24 hours. Pain Scale is recorded &quot;0&quot; = no pain, &quot;10&quot; = the most pain imaginable.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Oral morphine equivalent of consumed opioids</measure>
    <time_frame>Post-operatively to hospital discharge, up to 10 days.</time_frame>
    <description>Difference of post-operative opioid use between the concussion and non-concussion group</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of hospital stay</measure>
    <time_frame>Post-operatively to hospital discharge, up to 30 days.</time_frame>
    <description>Difference between the concussion and non-concussion group</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cognitive Deficits identified by NeuroPsychometric Cognitive Testing</measure>
    <time_frame>Pre-anesthetic to one week Post-anesthetic</time_frame>
    <description>Difference between the concussion and non-concussion group.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sport Concussion Assessment Tool - 5th edition, SCAT-5</measure>
    <time_frame>Pre-anesthetic to one week Post-anesthetic</time_frame>
    <description>The SCAT5 is a standardized tool for evaluating concussions designed for use by physicians and licensed medical professionals. Difference in SCAT5 scores between the concussion and non-concussion group. SCAT5 scores the number of symptoms (0-22) present and the severity of symptoms (0-132).</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Concussion, Brain</condition>
  <arm_group>
    <arm_group_label>Concussion Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects diagnosed with concussion defined as a clinician-diagnosed disease by the International Classification of Diseases (ICD)-10 due to a head injury with a Glasgow Coma Score ≥13 undergoing a planned surgery/anesthetic standard of care will undergo neurocognitive testing pre and post surgery/anesthetic.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Matched Subjects Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Matched subjects without concussion undergoing a planned surgery/anesthetic standard of care, matching for procedural type, sex, age ± 2 years, and adherence to the exclusion criteria will undergo neurocognitive testing pre and post surgery/anesthetic.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Neurocognitive Testing</intervention_name>
    <description>A comprehensive assessment of neuropsychometric measures to evaluate cognitive functioning.</description>
    <arm_group_label>Concussion Group</arm_group_label>
    <arm_group_label>Matched Subjects Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male or Female &gt;16 years of age with a recent concussion (&lt;10 weeks) from planned
             procedure under anesthesia.

        Exclusion Criteria:

          -  Neurologic history including history of severe cognitive disease, disorder, or delay,
             attention disorder, moderate to severe TBI history, neurovascular order or trauma.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>16 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Arnoley S Abcejo, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mayo Clinic</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Amy L Amsbaugh</last_name>
    <phone>507-538-7538</phone>
    <email>amsbaugh.amy@mayo.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Brenda Anderson</last_name>
    <phone>507-255-7157</phone>
    <email>anderson.brenda@mayo.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Mayo Clinic in Rochester</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55905</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Amy L Amsbaugh</last_name>
    </contact>
    <investigator>
      <last_name>Arnoley S Abcejo, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>https://www.mayo.edu/research/clinical-trials</url>
    <description>Mayo Clinic Clinical Trials</description>
  </link>
  <verification_date>August 2019</verification_date>
  <study_first_submitted>April 9, 2019</study_first_submitted>
  <study_first_submitted_qc>May 14, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">May 16, 2019</study_first_posted>
  <last_update_submitted>August 13, 2019</last_update_submitted>
  <last_update_submitted_qc>August 13, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">August 15, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mayo Clinic</investigator_affiliation>
    <investigator_full_name>Arnoley (Arney) S. Abcejo</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Brain Concussion</mesh_term>
    <mesh_term>Cognitive Dysfunction</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

